跳至主要内容
临床试验/IRCT20210707051810N1
IRCT20210707051810N1招募中3 期

Comparison of the effectiveness of Trazodone with placebo in preventing acute sleep disturbances caused by corticosteroid pulse in hospitalized patients with MS

Tehran University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with relapsing-remitting MS who are between 18 and 65 years old and hospitalized for treatment with corticosteroid pulse.
  • Hospitalized patients who are candidates for corticosteroid pulse at the rate of 1 gram per day for 3 to 5 days.

排除标准

  • Receiving other sleeping pills such as Barbiturates, Benzodiazepines, Doxepin, Melatonin and Zolpidem in the last 2 weeks
  • Having Primary Insomnia
  • Trazodone use in the last 2 weeks
  • Taking Monoamine oxidase inhibitor drugs in the last 2 weeks
  • History of hypersensitivity reaction to Trazodone or any components in the formulation
  • Severe chronic renal failure (Creatinine clearance less than 30 ml/min) and liver failure
  • Pregnancy and lactation
  • Patients receiving concomitant Intravenous immunoglobulin or plasma exchange other than Corticosteroid pulse

研究者

相似试验